J. Marsh's Profile

Role	Title	Level	Year	L/R
🐜	Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. 11 auth. P. Hillmen, C. Hall, J. Marsh, M. Elebute, M. Bombara, Beth E. Petro, ... M. Cullen, S. Richards, S. Rollins, C. Mojcik, R. Rother	9	2004	9 🐜
🐢	Guidelines for the diagnosis and management of adult aplastic anaemia 14 auth. S. Killick, N. Bown, J. Cavenagh, I. Dokal, T. Foukaneli, A. Hill, P. Hillmen, R. Ireland, A. Kulasekararaj, G. Mufti, ... J. Snowden, S. Samarasinghe, Anna Wood, J. Marsh	9	2016	9 🐢
🐜	In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. 21 auth. Panagiotis D. Kottaridis, D. Milligan, R. Chopra, R. Chakraverty, S. Chakrabarti, S. Robinson, K. Peggs, S. Verfuerth, R. Pettengell, J. Marsh, ... S. Schey, P. Mahendra, G. Morgan, G. Hale, H. Waldmann, M. de Elvira, C. Williams, S. Devereux, D. Linch, A. Goldstone, S. Mackinnon	9	2000	9 🐜
🦁	Guidelines for the diagnosis and management of aplastic anaemia 13 auth. J. Marsh, S. Ball, J. Cavenagh, P. Darbyshire, I. Dokal, E. Gordon-Smith, J. Keidan, A. Laurie, Anna Martin, J. Mercieca, ... S. Killick, R. Stewart, J. Yin	9	2009	9 🦁
🐢	A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. 8 auth. H. Pearson, J. Lobel, S. Kocoshis, J. Naiman, J. Windmiller, A. Lammi, ... R. Hoffman, J. Marsh	8	1979	8 🐢
🐜	Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT * SAA Working Party 15 auth. A. Bacigalupo, J. Hows, E. Gluckman, C. Nissen, J. Marsh, M. V. Lint, M. Congiu, M. Planque, P. Ernst, S. McCann, ... A. Ragavashar, N. Frickhofen, A. Würsch, A. Marmont, E. Gordon-Smith	8	1988	8 🐜
🐜	Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. 16 auth. H. Schrezenmeier, J. Passweg, J. Marsh, A. Bacigalupo, C. Bredeson, E. Bullorsky, B. Camitta, R. Champlin, R. Gale, M. Fuhrer, ... J. Klein, A. Locasciulli, R. Oneto, A. Schattenberg, G. Socié, M. Eapen	8	2007	8 🐜
🐜	Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience. 15 auth. A. Bacigalupo, R. Brand, R. Oneto, B. Bruno, Gerard Sodé, J. Passweg, A. Locasciulli, M. T. Lint, A. Tichelli, S. McCann, ... J. Marsh, P. Ljungman, J. Hows, P. Marín, H. Schrezenmeier	8	2000	8 🐜
🐜	TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis 13 auth. A. Kulasekararaj, Alexander Smith, S. Mian, A. Mohamedali, P. Krishnamurthy, N. Lea, Joop Gäken, C. Pennaneach, R. Ireland, B. Czepulkowski, ... S. Pomplun, J. Marsh, G. Mufti	7	2013	7 🐜
🐜	Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia. 20 auth. S. Tauro, C. Craddock, K. Peggs, G. Begum, P. Mahendra, G. Cook, J. Marsh, D. Milligan, A. Goldstone, A. Hunter, ... A. Khwaja, R. Chopra, T. Littlewood, A. Peniket, A. Parker, G. Jackson, G. Hale, M. Cook, N. Russell, S. Mackinnon	7	2005	7 🐜
🐜	Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. 10 auth. A. Kulasekararaj, Jie Jiang, Alexander Smith, A. Mohamedali, S. Mian, Shreyans Gandhi, ... J. Gaken, B. Czepulkowski, J. Marsh, G. Mufti	7	2014	7 🐜
🐜	Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria. 8 auth. A. Hill, P. Hillmen, S. Richards, D. Elebute, J. Marsh, Jason Chan, ... C. Mojcik, R. Rother	7	2005	7 🐜